BioSpace News Archive

Ancestry®, the global leader in family history and consumer genomics, announced it has made a $1 million educational grant to UpToDate®, a leading evidence-based clinical resource, to independently develop information for healthcare providers to help them interpret and act on the results of genetic testing

Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics using cell mechanics and machine learning, today announced $15 million in financing to advance its technology enabling early detection of sepsis in the emergency department.

Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, will host three corporate workshops and present multiple scientific posters highlighting their rapidly expanding product portfolio and industry collaborations at the upcoming 2019 Association for Molecular Pathology (AMP) Annual Meeting & Expo November 7-9 in Baltimore.

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MGI International Sales Co., Limited, a subsidiary of global genomics leader BGI Group, announced a co-marketing agreement for Twist Bioscience’s target enrichment product line in Europe and Asia Pacific.

Findings derived from Afirma Xpression Atlas analysis of company’s extensive biorepository of thyroid nodule fine needle aspiration samples

NewLink Genetics Corporation announced it will host its third quarter 2019 conference call and webcast at 8:30 AM ET on Wednesday, November 6, 2019, to discuss its third quarter financial results and provide an update on corporate activities.

National Comprehensive Cancer Network expands resources to meet growing utilization of cell-based cancer treatments

Galmed Pharmaceuticals Ltd. announced that it will host a conference call and webcast on Wednesday, November 6, 2019, to provide an update on current developments with respect to its clinical programs for Aramchol™ and to discuss financial results for the three and nine months ended September 30, 2019.

Program Creates a Consistent Regulatory Framework for Hemp Production Throughout the United States

Atacama Bio Natural Products s.a. and Lus Health Ingredients b.v. announce a distributorship on the NatAxtin™ range of products for the European market..